Literature DB >> 6766650

Long-term therapy of heart failure with prazosin: a randomized double blind trial.

W S Colucci, J Wynne, B L Holman, E Braunwald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6766650     DOI: 10.1016/0002-9149(80)90656-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  27 in total

Review 1.  Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III.

Authors:  J N Cohn
Journal:  Drugs       Date:  1994       Impact factor: 9.546

2.  Measurement of the quality of life in congestive heart failure-Influence of drug therapy.

Authors:  Christopher J Bulpitt; Astrid E Fletcher
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

Review 3.  Drug treatment of heart failure.

Authors:  C T Dollery; L Corr
Journal:  Br Heart J       Date:  1985-09

Review 4.  Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification.

Authors:  M Packer
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

5.  Treatment of chronic heart failure: a review of recent drug trials.

Authors:  D P Lipkin; P A Poole-Wilson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

Review 6.  Recent advances in cardiology.

Authors:  E A Rodrigues; D J Coltart
Journal:  Postgrad Med J       Date:  1982-08       Impact factor: 2.401

7.  Prazosin for refractory cardiac failure in children.

Authors:  H Netz; K J Hagel; G Röhner; H W Rautenburg
Journal:  Pediatr Cardiol       Date:  1984       Impact factor: 1.655

8.  Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.

Authors:  A D Timmis; P Smyth; J F Kenny; S Campbell; D E Jewitt
Journal:  Br Heart J       Date:  1984-09

Review 9.  Effect of drug treatment on quality of life in mild to moderate heart failure.

Authors:  D G Waller
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

10.  Muscle metaboreflex-induced coronary vasoconstriction limits ventricular contractility during dynamic exercise in heart failure.

Authors:  Matthew Coutsos; Javier A Sala-Mercado; Masashi Ichinose; Zhenhua Li; Elizabeth J Dawe; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.